The Marion Gluck Clinic

The safety of 52 weeks of oral DHEA therapy for postmenopausal women.

This study aimed to evaluate the safety of DHEA for post-menopausal women. The women in the study were randomised to receive a daily dose of 50mg oral DHEA or a placebo. Over 52 weeks, the effects of DHEA versus the placebo on lipid profile, insulin-glucose homeostasis and the endometrium were studied. Overall, the study found that the administration of 50mg DHEA daily did not significantly affect the lipid profile, insulin sensitivity or the endometrium.

Balance Health Energy